AI Detects Missed Lung Cancers on X-rays

New ARRS 2026 data shows FDA-cleared AI catching lung cancers radiologists missed — the implications for screening programs are significant

What if AI could catch the lung cancer your doctor missed?

New data presented at ARRS 2026 stopped the radiology community in its tracks. An FDA-cleared AI platform demonstrated the ability to detect lung cancers on chest X-rays that were retrospectively confirmed to have been missed by human radiologists — cancers that were present on prior imaging but not identified until they had progressed to a more advanced stage.

📊 The numbers are significant. Lung cancer remains the leading cause of cancer death in the United States, killing approximately 125,000 Americans per year. The five-year survival rate for stage I lung cancer exceeds 80 percent. For stage IV, it drops below 10 percent. The difference between those outcomes is almost entirely a function of when the cancer is detected. Every missed finding on a prior chest X-ray represents a patient whose survival odds deteriorated while the cancer grew undetected.

The ARRS data adds to a growing body of evidence that AI-assisted chest X-ra…